CDK11 Mediates Autophagy to Promote Breast Cancer Cell Proliferation and Migration by Regulating BCL-2

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Biology

Background:

• Cyclin-dependent kinase 11 (CDK11) is overexpressed in breast cancer, correlating with poor outcomes.
• The precise mechanisms of CDK11 in breast cancer progression are not fully understood.

Purpose of the Study:

• To investigate the role of CDK11 in breast cancer proliferation, migration, and autophagy.
• To elucidate the regulatory mechanisms involving CDK11, autophagy, and BCL-2 in breast cancer.

Main Methods:

• CDK11 inhibition and knockdown in breast cancer cells.
• Autophagy inhibition using chloroquine (CQ) and ATG7 knockdown.
• Gene expression profiling and BCL-2 overexpression studies.
• In vivo studies using a mouse subcutaneous xenograft tumor model.

Main Results:

• CDK11 inhibition suppressed breast cancer cell proliferation and migration while inducing autophagy.
• Blocking autophagy reversed the inhibitory effects of CDK11 reduction.
• CDK11 knockdown downregulated the anti-apoptotic factor BCL-2.
• BCL-2 overexpression partially rescued autophagy and reversed proliferation/migration inhibition.
• In vivo, BCL-2 overexpression partially rescued tumor growth inhibition caused by CDK11 knockdown.

Conclusions:

• CDK11 inhibition induces autophagy, which in turn suppresses breast cancer cell proliferation and migration.
• CDK11 mediates autophagy to promote breast cancer progression, with BCL-2 playing a key regulatory role.
• CDK11 represents a promising therapeutic target for human breast cancer.